![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 19
2024
Brioli, Annamaria 
ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia, Bd. 38: S. 1072-1080
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia, Bd. 38: S. 1072-1080
[PDF, 1MB]
Mahon, Francois-Xavier ORCID: https://orcid.org/0000-0003-1545-6775; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Dulucq, Stéphanie ORCID: https://orcid.org/0000-0003-2728-7243; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Panayiotidis, Panayiotis; Almeida, Antonio ORCID: https://orcid.org/0000-0003-4361-0928; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Hjorth-Hansen, Henrik ORCID: https://orcid.org/0000-0002-2670-5696; Janssen, Jeroen J.W.M.; Mustjoki, Satu ORCID: https://orcid.org/0000-0002-0816-8241; Martinez-Lopez, Joaquin ORCID: https://orcid.org/0000-0001-7908-0063; Vestergaard, Hanne; Ehrencrona, Hans ORCID: https://orcid.org/0000-0002-5589-3622; Machová Poláková, Katerina; Olsson-Strömberg, Ulla; Ossenkoppele, Gert; Berger, Marc G. ORCID: https://orcid.org/0000-0003-1858-0587; Etienne, Gabriel ORCID: https://orcid.org/0000-0001-7600-4954; Dengler, Jolanta; Brümmendorf, Tim H. ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Réa, Delphine ORCID: https://orcid.org/0000-0001-5379-7461; Rousselot, Philippe; Nicolini, Franck E.; Hofmann, Wolf-Karsten; Richter, Johan; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Mayer, Jiri; Voglová, Jaroslava; Faber, Edgar; Klamova, Hana; Vestergaard, Hanne; Koskenvesa, Perttu; Mahon, Francois-Xavier; Etienne, Gabriel; Berger, Marc G.; Rousselot, Philippe; Nicolini, Franck E.; Charbonnier, Aude; Legros, Laurence; Réa, Delphine; Guilhot, François; Escoffre-Barbe, Martine; Huguet, Françoise; Gyan, Emmanuel; Brümmendorf, Tim Henrik; Waller, Cornelius; Dengler, Jolanta; Hochhaus, Andreas; Saußele, Susanne; Burchert, Andreas; Kunzmann, Volker; Pagoni, Maria N.; Panayiotidis, Panayiotis; Janssen, Jeroen J.W.M.; Ossenkoppele, Gert; Westerweel, Peter E.; Greef, Georgine E. de; Gruber, Franz; Hjorth-Hansen, Henrik; Almeida, Antonio; Martinez-Lopez, Joaquin; Lotfi, Kourosh; Richter, Johan; Stenke, Leif; Olsson-Strömberg, Ulla und Söderlund, Stina
(2024):
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.
In: Journal of Clinical Oncology, Bd. 42, Nr. 16: S. 1875-1880
[PDF, 868kB]
ORCID: https://orcid.org/0000-0003-1545-6775; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Dulucq, Stéphanie ORCID: https://orcid.org/0000-0003-2728-7243; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Panayiotidis, Panayiotis; Almeida, Antonio ORCID: https://orcid.org/0000-0003-4361-0928; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Hjorth-Hansen, Henrik ORCID: https://orcid.org/0000-0002-2670-5696; Janssen, Jeroen J.W.M.; Mustjoki, Satu ORCID: https://orcid.org/0000-0002-0816-8241; Martinez-Lopez, Joaquin ORCID: https://orcid.org/0000-0001-7908-0063; Vestergaard, Hanne; Ehrencrona, Hans ORCID: https://orcid.org/0000-0002-5589-3622; Machová Poláková, Katerina; Olsson-Strömberg, Ulla; Ossenkoppele, Gert; Berger, Marc G. ORCID: https://orcid.org/0000-0003-1858-0587; Etienne, Gabriel ORCID: https://orcid.org/0000-0001-7600-4954; Dengler, Jolanta; Brümmendorf, Tim H. ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Réa, Delphine ORCID: https://orcid.org/0000-0001-5379-7461; Rousselot, Philippe; Nicolini, Franck E.; Hofmann, Wolf-Karsten; Richter, Johan; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Mayer, Jiri; Voglová, Jaroslava; Faber, Edgar; Klamova, Hana; Vestergaard, Hanne; Koskenvesa, Perttu; Mahon, Francois-Xavier; Etienne, Gabriel; Berger, Marc G.; Rousselot, Philippe; Nicolini, Franck E.; Charbonnier, Aude; Legros, Laurence; Réa, Delphine; Guilhot, François; Escoffre-Barbe, Martine; Huguet, Françoise; Gyan, Emmanuel; Brümmendorf, Tim Henrik; Waller, Cornelius; Dengler, Jolanta; Hochhaus, Andreas; Saußele, Susanne; Burchert, Andreas; Kunzmann, Volker; Pagoni, Maria N.; Panayiotidis, Panayiotis; Janssen, Jeroen J.W.M.; Ossenkoppele, Gert; Westerweel, Peter E.; Greef, Georgine E. de; Gruber, Franz; Hjorth-Hansen, Henrik; Almeida, Antonio; Martinez-Lopez, Joaquin; Lotfi, Kourosh; Richter, Johan; Stenke, Leif; Olsson-Strömberg, Ulla und Söderlund, Stina
(2024):
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.
In: Journal of Clinical Oncology, Bd. 42, Nr. 16: S. 1875-1880
[PDF, 868kB]
Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Mahon, François-Xavier und Richter, Johan ORCID: https://orcid.org/0000-0002-0374-6823
(2024):
How to interpret the EURO-SKI study and its treatment-free remission outcome. Reply to R.P. Gale and J. Chen.
In: Leukemia, Bd. 38, Nr. 2: S. 460-462
[PDF, 375kB]
ORCID: https://orcid.org/0000-0002-8948-0690; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Mahon, François-Xavier und Richter, Johan ORCID: https://orcid.org/0000-0002-0374-6823
(2024):
How to interpret the EURO-SKI study and its treatment-free remission outcome. Reply to R.P. Gale and J. Chen.
In: Leukemia, Bd. 38, Nr. 2: S. 460-462
[PDF, 375kB]
2023
Isfort, Susanne ORCID: https://orcid.org/0000-0002-2855-561X; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Teichmann, Lino L.; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander; Göthert, Joachim R.; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Hänel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Wolf, Dominik und Brümmendorf, Tim H.
(2023):
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
In: Annals of Hematology, Bd. 102: S. 2741-2752
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-2855-561X; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Teichmann, Lino L.; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander; Göthert, Joachim R.; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Hänel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Wolf, Dominik und Brümmendorf, Tim H.
(2023):
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
In: Annals of Hematology, Bd. 102: S. 2741-2752
[PDF, 1MB]
2022
Schönfeld, Lioba; Rinke, Jenny; Hinze, Anna; Nagel, Saskia N.; Schäfer, Vivien; Schenk, Thomas; Fabisch, Christian; Brümmendorf, Tim H. ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Coutre, Philipp le; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Safizadeh, Fatemeh; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X
(2022):
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia.
In: Leukemia, Bd. 36: S. 2242-2249
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Coutre, Philipp le; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Safizadeh, Fatemeh; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X
(2022):
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia.
In: Leukemia, Bd. 36: S. 2242-2249
[PDF, 1MB]
2021
Egeli, Damla Buket; Hanfstein, Benjamin; Lauseker, Michael; Pfirrmann, Markus; Saussele, Susanne; Baerlocher, Gabriela M. und Müller, Martin C.
(2021):
SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment.
In: Leukemia & Lymphoma, Bd. 63, Nr. 4: S. 955-962
Egeli, Damla Buket; Hanfstein, Benjamin; Lauseker, Michael; Pfirrmann, Markus; Saussele, Susanne; Baerlocher, Gabriela M. und Müller, Martin C.
(2021):
SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment.
In: Leukemia & Lymphoma: S. 1-8
2020
Saussele, Susanne; Haverkamp, Wilhelm; Lang, Fabian; Koschmieder, Steffen; Kiani, Alexander; Jentsch-Ullrich, Kathleen; Stegelmann, Frank; Pfeifer, Heike; La Rosee, Paul; Goekbuget, Nicola; Rieger, Christina; Waller, Cornelius F.; Franke, Georg-Nikolaus; le Coutre, Philipp; Kirchmair, Rudolf und Junghanss, Christian
(2020):
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
In: Acta Haematologica, Bd. 143, Nr. 3: S. 217-231
Pfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael; Baccarani, Michele; Saussele, Susanne; Guilhot, François; Hasford, Joerg; Hochhaus, Andreas und Hoffmann, Verena S.
(2020):
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
In: Leukemia, Bd. 34, Nr. 8: S. 2138-2149
[PDF, 969kB]
2019
Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W.; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Alice and Haferlach und Pfirrmann, Markus
(2019):
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
In: Haematologica, Bd. 104, Nr. 5: S. 955-962
2018
Rinaldetti, Sébastien; Pfirrmann, Markus; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Guilhot, Joelle; Dietz, Christian; Panagiotidis, Panayiotidis; Spiess, Birgit; Seifarth, Wolfgang; Fabarius, Alice; Müller, Martin; Pagoni, Maria; Dimou, Maria; Dengler, Jolanta; Waller, Cornelius F.; Brümmendorf, Tim H.; Herbst, Regina; Burchert, Andreas; Janßen, Carsten; Goebeler, Maria Elisabeth; Jost, Philipp J.; Hanzel, Stefan; Schafhausen, Philippe; Prange-Krex, Gabriele; Illmer, Thomas; Janzen, Viktor; Klausmann, Martine; Eckert, Robert; Büschel, Gerd; Kiani, Alexander; Hofmann, Wolf-Karsten; Mahon, François-Xavier und Saussele, Susanne
(April 2018):
Effect of ABCG2, OCT1, and ABCB1(MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.
In: Clinical Lymphoma, Myeloma & Leukemia, Bd. 18, Nr. 4: S. 266-271
[PDF, 462kB]
ORCID: https://orcid.org/0000-0002-7740-4076; Guilhot, Joelle; Dietz, Christian; Panagiotidis, Panayiotidis; Spiess, Birgit; Seifarth, Wolfgang; Fabarius, Alice; Müller, Martin; Pagoni, Maria; Dimou, Maria; Dengler, Jolanta; Waller, Cornelius F.; Brümmendorf, Tim H.; Herbst, Regina; Burchert, Andreas; Janßen, Carsten; Goebeler, Maria Elisabeth; Jost, Philipp J.; Hanzel, Stefan; Schafhausen, Philippe; Prange-Krex, Gabriele; Illmer, Thomas; Janzen, Viktor; Klausmann, Martine; Eckert, Robert; Büschel, Gerd; Kiani, Alexander; Hofmann, Wolf-Karsten; Mahon, François-Xavier und Saussele, Susanne
(April 2018):
Effect of ABCG2, OCT1, and ABCB1(MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.
In: Clinical Lymphoma, Myeloma & Leukemia, Bd. 18, Nr. 4: S. 266-271
[PDF, 462kB]
Saussele, Susanne; Richter, Johan; Guilhot, Joelle; Gruber, Franz X.; Hjorth-Hansen, Henrik; Almeida, Antonio; Janssen, Jeroen J. W. M.; Mayer, Jiri; Koskenvesa, Perttu; Panayiotidis, Panayiotis; Olsson-Strömberg, Ulla; Martinez-Lopez, Joaquin; Rousselot, Philippe; Vestergaard, Hanne; Ehrencrona, Hans; Kairisto, Veli; Machová Poláková, Katerina; Müller, Martin C.; Mustjoki, Satu; Berger, Marc G.; Fabarius, Alice; Hofmann, Wolf-Karsten; Hochhaus, Andreas; Pfirrmann, Markus und Mahon, Francois-Xavier
(2018):
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): A prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
In: The Lancet, Bd. 19, Nr. 6: S. 747-757
Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W.; Hofmann, Wolf-Karsten; Hasford, Joerg; Pfirrmann, Markus; Müller, Martin C.; Hochhaus, Andreas und Lauseker, Michael
(2018):
Defining therapy goals for major molecular remission in chronic myeloid leukemia: Results of the randomized CML Study IV.
In: Leukemia, Bd. 32, Nr. 5: S. 1222-1228
[PDF, 599kB]
Schütz, C.; Inselmann, S.; Saussele, Susanne; Dietz, C. T.; Müller, M. C.; Eigendorff, E.; Brendel, C. A.; Metzelder, S. K.; Brümmendorf, T. H.; Waller, C.; Dengler, J.; Goebeler, M. E.; Herbst, R.; Freunek, G.; Hanzel, S.; Illmer, Thomas; Wang, Y.; Lange, T.; Finkernagel, F.; Hehlmann, Rüdiger; Huber, M.; Neubauer, A.; Hochhaus, Andreas; Guilhot, Joelle; Mahon, F. X.; Pfirrmann, Markus und Burchert, A.
(2018):
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
In: Leukemia, Bd. 32, Nr. 4
2017
Sebastien, R.; Sticht, C.; Pfirrmann, M.; Nowak, Dennis ORCID: https://orcid.org/0000-0001-7871-8686; Fabarius, A.; Seifarth, W.; Spiess, B.; Panayiotidis, P.; Pagoni, M.; Dimou, M.; Dengler, J.; Waller, C. F.; Brümmendorf, T. H.; Burchert, A.; Freunek, G.; Hofmann, W.-K.; Mahon, F.-X. und Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2017):
The EUROSKI biomarker study: Analyzing the mechanisms of treatment-free remission in chronic myeloid leukemia.
42nd ESMO Congress (ESMO 2017), Madrid, Spain, 8-12 September 2017.
Annals of Oncology.
Bd. 28, Nr. Suppl. 5
Oxford University Press.
v367
ORCID: https://orcid.org/0000-0001-7871-8686; Fabarius, A.; Seifarth, W.; Spiess, B.; Panayiotidis, P.; Pagoni, M.; Dimou, M.; Dengler, J.; Waller, C. F.; Brümmendorf, T. H.; Burchert, A.; Freunek, G.; Hofmann, W.-K.; Mahon, F.-X. und Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2017):
The EUROSKI biomarker study: Analyzing the mechanisms of treatment-free remission in chronic myeloid leukemia.
42nd ESMO Congress (ESMO 2017), Madrid, Spain, 8-12 September 2017.
Annals of Oncology.
Bd. 28, Nr. Suppl. 5
Oxford University Press.
v367
Schütz, C.; Inselmann, S.; Saussele, Susanne; Dietz, C. T.; Müller, M. C.; Brendel, C. A.; Metzelder, S. K.; Brümmendorf, Tim H.; Waller, C.; Dengler, J.; Goebeler, M. E.; Herbst, R.; Hanzel, S.; Freunek, G.; Illmer, T.; Wang, Y.; Lange, T.; Finkernagel, F.; Hehlmann, R.; Huber, M.; Neubauer, A.; Hochhaus, A.; Guilhot, J.; Xavier Mahon, F.; Pfirrmann, Markus und Burchert, A.
(2017):
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
In: Leukemia, Bd. 31: S. 829-836
Lauseker, Michael; Hasford, Joerg; Saussele, Susanne; Kremers, Stephan; Kraemer, Doris; Lindemann, Walter; Hehlmann, Rüdiger und Pfirrmann, Markus
(2017):
Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death.
In: Cancer, Bd. 123, Nr. 13: S. 2467-2471
2014
Lindörfer, Doris; Hoffmann, Verena S.; Rosti, Gianantonio; Castagnetti, Fausto; Saussele, Susanne; Guilhot, Joelle; Simonsson, Bengt; Steegmann, Juan Luis; Mayer, Jiri; Indrak, Karel; Turkina, Anna G; Zaritskey, Andrey; Labar, Boris; Zupan, Irena P; Thielen, Noortje; Clark, Richard E; Thaler, Josef; Melanthiou, Frederiki; Everaus, Hele; Porkka, Kimmo; Bogdanovic, Andrija; Schubert-Fritschle, Gabriele; Panagiotidis, Panagiotis; Masszi, Tamas; Lejniece, Sandra; Griskevicius, Laimonas; Hellmann, Andrzej; Prejzner, Witold; Sacha, Tomasz; Almeida, Antonio; Dyagil, Iryna; Colita, Adriana; Mihaylov, Georgi; Hehlmann, Rüdiger; Hasford, Joerg und Baccarani, Michele
(Juni 2014):
The EUTOS population-based registry: evaluation of baseline characteristics and first treatment choices of 2983 newly diagnosed chronic myeloid leukemia (CML) patients from 20 European countries.
19th Congress of the European Hematology Association (EHA), Mailand, Italien, 12. – 15. Juni 2014.
Haematologica.
Bd. 99, Nr. Suppl. 1
Ferrata Storti Foundation.
Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W.; Schubert, Joerg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Jörg; Hofmann, Wolf-Karsten; Hochhaus, Andreas und Müller, Martin C.
(2014):
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.
In: Haematologica, Bd. 99, Nr. 9: S. 1441-1447
[PDF, 784kB]